榮豐集團(08526.HK)折讓約14.8%配售7,500萬股 淨籌1,010萬元
榮豐集團亞洲(08526)宣布與配售代理訂立配售協議,計劃配售最多7,500萬股股份,佔擴大後公司已發行股本約11.56%,配售價每股0.144元,較前收市價每股0.169元折讓約14.8%。
配售事項所得款項總額約1,080萬元,配售事項所得款項淨額約為1,010萬元,擬撥作集團一般營運資金。
此外,公司指更改上市所得款項淨額用途,原本分配至增聘員工及提供相關培訓,以及在澳門租賃新辦公室及增聘員工的未動用所得款項淨額約200萬元,將更改用途至撥充集團一般營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.